Dr. Victor E Lambert, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3214 Roosevelt Hwy, Manchester, GA 31816 Phone: 706-846-3151 Fax: 706-846-2768 |
News Archive
QLT Inc. today announced results from Phase II clinical trials and a device study for the punctal plug delivery system (PPDS). These studies are part of a development program that is being conducted by QLT's wholly-owned subsidiary, QLT Plug Delivery, Inc. QLT also announced its plans to expand the program to evaluate a second drug for a new target indication.
Members of Congress are scrambling to lower the cost of a bill to fix veterans' health care amid a growing uproar over long waits for appointments, meanwhile, The Wall Street Journal is reporting that congressional inaction is threatening a program for brain-damaged vets.
Prednisone, the current standard of care used to treat kids with Duchenne muscular dystrophy (DMD), reduces chronic inflammation but has harsh side effects.
The Michael J. Fox Foundation for Parkinson's Research (MJFF) will provide $2.5 million to support Ceregene Inc.'s new Phase 2 study of CERE-120. This novel gene therapy product delivers the gene for neurturin, a potent neurotrophic (growth) factor that has shown potential to improve the status of degenerating neurons in both preclinical and clinical studies. CERE-120 has the potential to improve motor function as well as slow Parkinson's disease (PD) progression.
A case presented to the Southwark Coroner's Court heard that doctors continued operating on Kelly McLure, 31, after she suffered her cardiac arrest at the private Belvedere Hospital, in Kent. The paramedics were kept waiting for 45 minutes despite insisting on taking her straight to A&E. However her surgeons Dr Edward Latimer-Sayer and Dr Ahmed el Sayed Moustafa, the anaesthetist, continued with the routine nose and chin procedure after stabilizing her.
› Verified 6 days ago